Chen X H, Harden T K, Nicholas R A
Department of Pharmacology, University of North Carolina at Chapel Hill 27599-7365.
J Biol Chem. 1994 Oct 7;269(40):24810-9.
In an attempt to isolate new G protein-coupled receptors from turkey erythrocytes, reverse transcribed polymerase chain reaction was performed on fetal turkey blood RNA using degenerate primers based on conserved sequences present in seven transmembrane receptors. An open reading frame in one of the clones, designated 4C (497 base pairs), displayed approximately 50-60% identity to all of the previously cloned beta-adrenergic receptors (beta-ARs). A lambda-DASH turkey genomic library was screened with a probe generated from the partial 4C cDNA, and the gene encoding this receptor was localized to a 3.5-kilobase pair HindIII fragment. Ribonuclease protection analysis of turkey lung mRNA indicated that the 3' end of the coding sequence of the 4C gene, like beta 3-AR, was interrupted by an intron. To obtain the cDNA sequence of 4C, RNA-polymerase chain reaction was performed using primers complementary to regions identified by ribonuclease protection analysis to be present in 4C mRNA. Comparison of the genomic and cDNA sequences of 4C indicated that the first exon encodes 414 amino acids of the protein, the second exon (68 base pairs) encodes an additional 12 residues followed by a stop codon, and the third exon is composed of 3'-untranslated sequence. The 4C receptor was transiently expressed in COS-1 cells, and the apparent affinities of a series of beta-AR agonists and antagonists were determined using [125I]iodocyanopindolol. As implicated by its amino acid sequence, 4C displayed a pharmacological selectivity that was consistent with that of a beta-AR but distinct from other cloned beta-ARs. Isoproterenol, epinephrine, and norepinephrine stimulated cyclic AMP accumulation in a concentration-dependent manner in mouse L cells stably expressing the 4C receptor. No effect on phospholipase C activity was observed. Ribonuclease protection assays indicated that 4C mRNA exhibits a broad tissue distribution, which suggests that it may play an important role in avian physiology.
为了从火鸡红细胞中分离出新的G蛋白偶联受体,利用基于七个跨膜受体中保守序列的简并引物,对火鸡胎儿血液RNA进行逆转录聚合酶链反应。在其中一个克隆(命名为4C,497个碱基对)中发现的一个开放阅读框,与所有先前克隆的β-肾上腺素能受体(β-ARs)显示出约50-60%的同源性。用从部分4C cDNA产生的探针筛选λ-DASH火鸡基因组文库,编码该受体的基因定位于一个3.5千碱基对的HindIII片段。对火鸡肺mRNA的核糖核酸酶保护分析表明,4C基因编码序列的3'端,与β3-AR一样,被一个内含子中断。为了获得4C的cDNA序列,使用与核糖核酸酶保护分析确定存在于4C mRNA中的区域互补的引物进行RNA聚合酶链反应。4C的基因组和cDNA序列比较表明,第一个外显子编码该蛋白的414个氨基酸,第二个外显子(68个碱基对)编码另外12个残基,随后是一个终止密码子,第三个外显子由3'非翻译序列组成。4C受体在COS-1细胞中瞬时表达,使用[125I]碘氰吲哚洛尔测定了一系列β-AR激动剂和拮抗剂的表观亲和力。如其氨基酸序列所示,4C表现出与β-AR一致但与其他克隆的β-AR不同的药理学选择性。异丙肾上腺素、肾上腺素和去甲肾上腺素在稳定表达4C受体的小鼠L细胞中以浓度依赖的方式刺激环磷酸腺苷积累。未观察到对磷脂酶C活性的影响。核糖核酸酶保护试验表明。4C mRNA表现出广泛的组织分布,这表明它可能在禽类生理学中起重要作用。